Doctors' Choice names top ads

The Association of Medical Media announced 13 finalists in The Doctors' Choice awards for best journal ads.

According to the AMM, 5,742 docs reviewed 327 ads, representing 200 of the most widely advertised products in 2007. 

Ad criteria for judging included the “ability to communicate clearly and quickly, help with clinical decisions, prompt seeking more information or re-examining treatment, generate interest, add to information provided by company sales reps and underscore the value of the product prescribed,” according to an AMM statement. Winners will be announced at a luncheon at The Palace Hotel on September 24, in New York City. 
You must be a registered member of MMM to post a comment.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.